Identification and characterization of Steroidogenic Factor-1 inverse agonists | |
Assessment of inverse agonism for the angiotensin II type 1 receptor | |
Measurement of inverse agonism in BARs | |
Inverse agonism of antidepressants: in vitro and in vivo studies | |
Differential inverse agonism at the human muscarinic M3 receptor | |
Ghrelin Receptor: High Constitutive Activity and Methods for Developing Inverse Agonists | |
Constitutive activity and inverse agonism at the a1a and a1b adrenergic receptor subtypes | |
Measurement of inverse agonism of the cannabinoid receptor | |
Constitutively Active Thyrotropin (TSH) and Thyrotropin-Releasing Hormone (TRH) Receptors and Their Inverse Agonists | |
Inverse retinoid agonists and neutral antagonists | |
y-Aminobutyric Acid Type A (GABAA) Receptor Subtype Inverse Agonists as Therapeutic Agents in Cognition | |
Assays for inverse agonists in the visual system | |
Receptor-driven identification of novel human A3 adenosine receptor antagonists as potential therapeutic agents | |
Inverse agonists of steroidogenic factor SF-1 | |
Methods to Measure G Protein Coupled Receptor Activity for the Identification of Inverse Agonists | |
Novel Strategies and Techniques for Constitutive Activity and Inverse Agonism | |
Use of Pharmacoperones to Reveal GPCR Structural Components Associated with Receptor Activation and Trafficking | |
Application of large-scale transiently transfected cells to functional assays of ion channels and other proteins | |
Quantification of RNA Editing of the Serotonin 2C Receptor (5-HT2CR) Ex Vivo | |
Strategies for isolating constitutively-active and dominant-negative pheromone receptor mutants in yeast | |
Development of a GPR23 Cell-based ß-Lactamase Reporter Assay | |
Computational Modeling of Constitutively Active Mutants of GPCRs: C5a Receptor | |
TSH receptor monoclonal antibodies with agonist, antagonist and inverse agonist activities | |
Current standards, variations and pitfalls for the determination of constitutive TSHR activity in vitro | |
Towards the Rational Design of Constitutively Active KCa3.1 Mutant Channels | |
Fusion proteins as model systems for the analysis of constitutive GPCR activity | |
Screening for Novel Constitutively Active CXCR2 Mutants and Their Cellular Effects | |
A method for parallel solid-phase synthesis of iodinated analogues of the cannabinoid receptor type I (CB1) inverse agonist rimonabant | |
Coexpression systems as models for the analysis of constitutive GPCR activity | |
Modelling and simulation of inverse agonism dynamics | |
Design and Use of Constitutively Active STAT5 Constructs | |
In vitro and in vivo assays of protein kinase CK2 activity | |
Table of Contents provided by Publisher. All Rights Reserved. |